Home / Peptides / DSIP

DSIP Dosage: What the Evidence Says (2026)

Not FDA-approved

Nine-amino-acid sleep peptide from the 1970s. Mixed IV studies; advisory committee voted against it in 2026.

Also called: emideltide

Regulatory status (US)

Not approved. It was removed from the FDA's significant-risk list in April 2026, but in July 2026 the FDA advisory committee voted against allowing it for compounding (the only peptide rejected), and it is not in the HHS draft policy.

What it is

A nine-amino-acid peptide first isolated in rabbits in 1977 and studied for sleep.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for DSIP. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.

DSIP reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Safety

Questions

Is DSIP FDA-approved?
Not approved. It was removed from the FDA's significant-risk list in April 2026, but in July 2026 the FDA advisory committee voted against allowing it for compounding (the only peptide rejected), and it is not in the HHS draft policy.
What dose of DSIP has been studied?
There is no established human dose. Small European insomnia studies in the 1980s and 1990s used IV doses; results were mixed and one concluded a major benefit was unlikely. No data for injection under the skin.
How many units is my DSIP dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Sermorelin

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

BPC-157

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

Sources

  1. Bes et al. 1992: DSIP in insomnia (PubMed)
  2. Federal Register (public inspection) 2026-07361: peptide category changes
  3. Manufacturing Chemist: FDA panel backs six peptides for pharmacy compounding
  4. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.